SMTL ID : 6a5w.1 (1 other biounit)

FXR-LBD with HNC143 and SRC1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.88 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 9R0: 2-[2-[[3-[2,6-bis(chloranyl)phenyl]-5-cyclopropyl-1,2-oxazol-4-yl]methoxy]-6-azaspiro[3.4]octan-6-yl]-1,3-benzothiazole-6-carboxylic acid(Non-covalent)

9R0.1: 24 residues within 4Å: Chain A: M.22, T.27, I.30, F.41, L.44, T.45, M.47, A.48, H.51, M.85, F.86, R.88, S.89, I.92, L.97, P.98, H.101, L.105, Y.126, H.204, M.207, W.211, F.218, W.226 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:M.22, A:T.27, A:F.41, A:L.44, A:M.47, A:A.48, A:I.92, A:W.211, A:W.211, A:F.218, A:W.226 Hydrogen bonds: A:R.88 Salt bridges: A:H.101 pi-Stacking: A:F.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, N. et al., Ligand binding and heterodimerization with retinoid X receptor alpha (RXR alpha ) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding. J. Biol. Chem. (2018)

Release Date

2018-10-10

Peptides

Bile acid receptor: A
Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Bile acid receptor

Nuclear receptor coactivator 1

Related Entries With Identical Sequence